Andor Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANDOR PHARMS, and what generic and branded alternatives to ANDOR PHARMS drugs are available?
ANDOR PHARMS has one approved drug.
Summary for Andor Pharms
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Andor Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Andor Pharms | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211918-004 | Apr 24, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Andor Pharms | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211918-001 | Apr 24, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Andor Pharms | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211918-003 | Apr 24, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Andor Pharms | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211918-002 | Apr 24, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
